Showing 3941-3950 of 5646 results for "".
- New Nerve Insights Could Someday Help Heal Certain Types of Blindness and Paralysishttps://modernod.com/news/new-nerve-insights-could-someday-help-heal-certain-types-of-blindness-and-paralysis/2481666/A team of UConn School of Medicine researchers report in the journal Development that at least a small population of nerve cells exist in everyone tha
- Bausch + Lomb Launches Biotrue Hydration Boost Contact Lens Rehydrating Drops in the United Stateshttps://modernod.com/news/bausch-lomb-launches-biotrue-hydration-boost-contact-lens-rehydrating-drops-in-the-united-states/2481653/Bausch + Lomb announced the US launch of Biotrue Hydration Boost Contact Lens Rehydrating drops, which the company describes as the first and only preservative-free rehydrating drop in a multi-dose bottle that is indicated to lubricate and rewet soft contact lenses, including daily
- AOS Launches Remote Visual Acuity System Platformhttps://modernod.com/news/aos-launches-remote-visual-acuity-system-platform/2481652/AOS (Advanced Ophthalmic Systems) announced the launch of a new remote visual acuity software platform. The AOS VA software is a synchronous test that requires internet connection and can be used on multiple device types. Using a combination of semi-automated test algorithms a
- Bausch + Lomb Launches Infuse Multifocal Silicone Hydrogel Contact Lenses in the United Stateshttps://modernod.com/news/bausch-lomb-launches-infuse-multifocal-silicone-hydrogel-contact-lenses-in-the-united-states/2481649/Bausch + Lomb announced the US launch of Bausch + Lomb Infuse Multifocal silicone hydrogel (SiHy) daily disposable contact lenses. Featuring a new material infused with ProBalance Technology for all-day comfort and the company’s '3-Zone Progressive' design,
- Gamesquare Partners with Vivior to Help Gamers Build Healthy Screen Habitshttps://modernod.com/news/gamesquare-partners-with-vivior-to-help-gamers-build-healthy-screen-habits/2481646/GameSquare Holdings announced a multi-year, multi-million dollar partnership with Swiss vision care startup Vivior with the aim of promoting healthy digital habits, according to a company news release. Through content creation, product development, and competition, GameSquare and Vivior
- Optos Announces New Ultra-Widefield Color Image Modality, Providing Additional Retinal Visualizationhttps://modernod.com/news/optos-announces-new-ultra-widefield-color-image-modality-providing-additional-retinal-visualization/2481645/Optos announced it is expanding the optomap ultra-widefield (UWF) retinal imaging modalities in the California FA device to further assist eye care professionals in disease management and treatment planning. In addition to optomap color rg (red/green), sensory red-free, c
- Alimera Completes Recruitment for Its NEW DAY Study Evaluating Iluvien for DMEhttps://modernod.com/news/alimera-completes-recruitment-for-its-landmark-new-day-study/2481633/Alimera Sciences announced that it has completed enrollment for the company’s NEW DAY clinical trial, a randomized, controlled, multicenter study designed to generate prospective data for Iluvien (fluocinolone acetonide intravitreal implant, 0.19mg) as a baseline therapy in p
- iHealthScreen Announces FDA 510(k) Submission for iPredict Automated AI-Based AMD Toolhttps://modernod.com/news/ihealthscreen-announces-fda-510k-submission-for-ipredict-automated-ai-based-amd-tool/2481632/iHealthScreen has submitted for FDA 510(k) clearance for iPredict, making it the first company to apply for an FDA clearance for screening AMD, according to a company news release. iPredict AI Eye Screening System provides fully automated age-related macular degener
- NEI Scientists Publish Recipe for Making Blood Vessel Cells from Patient Stem Cellshttps://modernod.com/news/nei-scientists-publish-recipe-for-making-blood-vessel-cells-from-patient-stem-cells/2481626/Researchers at NIH’s National Eye Institute have published a detailed protocol for making three cell types that are key components to form blood vessels and capillaries. The technique enables researchers to make tissues for study and potentially for future treatments. &ldquo
- Alimera Acquires US Commercial Rights to Yutiqhttps://modernod.com/news/alimera-acquires-us-commercial-rights-to-yutiq/2481624/Alimera Sciences has acquired additional commercialization rights for Yutiq (fluocinolone acetonide intravitreal insert, 0.18mg) for the treatment of chronic noninfectious uveitis affecting the posterior segment of the eye from EyePoint Pharmaceuticals. Alimera now has exclusi